MHC Class I vs Class II: Key Differences & Functions [Guide]
MHC Class I vs Class II: Key Differences & Functions [Guide]
Major Histocompatibility Complex molecules present antigens to T cells so the immune system can identify infected and abnormal cells. This guide breaks down how MHC class I and class II differ in structure, expression and function — plus the validated antibodies to detect them.
Browse MHC & HLA Antibodies →Major Histocompatibility Complex (MHC) molecules are essential for immune recognition and response. They are specialized glycoproteins that present antigens to T cells, allowing the immune system to identify and eliminate pathogens or abnormal cells. MHC molecules are classified into Class I and Class II, each with distinct structures, functions, and roles in immune defense.
This article explores the differences between MHC class I and MHC class II, highlighting their unique features and immune significance.
1. Overview of MHC Molecules
MHC molecules play a crucial role in antigen presentation, enabling the adaptive immune system to recognize infected or abnormal cells.
- MHC Class I: Found on almost all nucleated cells; presents antigens to CD8+ cytotoxic T cells.
- MHC Class II: Found on antigen-presenting cells (APCs); presents antigens to CD4+ helper T cells.
2. Key Differences Between MHC Class I and MHC Class II
| Feature | MHC Class I | MHC Class II |
|---|---|---|
| Expression | Present on all nucleated cells. | Restricted to professional APCs (e.g., dendritic cells, macrophages, B cells). |
| Antigen Source | Endogenous (intracellular antigens, e.g., viral proteins). | Exogenous (extracellular antigens, e.g., bacterial toxins). |
| Associated T Cells | CD8+ cytotoxic T cells. | CD4+ helper T cells. |
| Peptide Binding Groove | Closed ends, binds peptides 8–10 amino acids long. | Open ends, binds peptides 13–25 amino acids long. |
| Structure | Composed of a heavy α chain and β2-microglobulin. | Composed of α and β chains of equal size. |
| Peptide Loading Site | Endoplasmic reticulum (ER). | Specialized endosomal compartments. |
| Function | Kills infected or abnormal cells. | Activates immune responses and helps B cells produce antibodies. |
3. Structure of MHC Class I and Class II
MHC Class I
- Structure: Consists of a heavy α chain (with α1, α2, and α3 domains) and a β2-microglobulin chain. The α1 and α2 domains form the peptide-binding groove. The groove accommodates short peptides (8–10 amino acids) due to its closed ends.
- Expression: Found on the surface of all nucleated cells, ensuring cytotoxic T cells can recognize infected or malignant cells.
MHC Class II
- Structure: Composed of two chains: α chain and β chain, each with two domains (α1/β1 and α2/β2). The α1 and β1 domains form the peptide-binding groove. The groove binds longer peptides (13–25 amino acids) because it has open ends.
- Expression: Restricted to antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells.
4. Antigen Processing and Presentation
MHC Class I Pathway
| Step | Details |
|---|---|
| Antigen Source | Endogenous antigens (e.g., viral proteins or tumor antigens). |
| Processing | Antigens are degraded by proteasomes into short peptides. |
| Peptide Loading | Peptides are transported into the ER by TAP (Transporter Associated with Antigen Processing), where they bind to MHC class I molecules. |
| Presentation | Peptide-MHC complexes are transported to the cell surface to present to CD8+ cytotoxic T cells. |
MHC Class II Pathway
| Step | Details |
|---|---|
| Antigen Source | Exogenous antigens (e.g., bacterial toxins, extracellular pathogens). |
| Processing | Antigens are taken up via phagocytosis or endocytosis and degraded in acidic endosomes. |
| Peptide Loading | MHC class II molecules bind peptides in a specialized endosomal compartment after the invariant chain is removed. |
| Presentation | Peptide-MHC complexes are transported to the cell surface to present to CD4+ helper T cells. |
5. Immune Functions
MHC Class I
- Activates CD8+ cytotoxic T cells, which kill infected or malignant cells by inducing apoptosis.
- Important for defending against intracellular pathogens, such as viruses.
MHC Class II
- Activates CD4+ helper T cells, which coordinate the immune response.
- Th1 cells: Enhance macrophage activity to kill intracellular bacteria.
- Th2 cells: Help B cells produce antibodies against extracellular pathogens.
- Essential for initiating adaptive immunity against extracellular pathogens.
6. Clinical Significance
| Disease/Condition | Role of MHC Molecules |
|---|---|
| Autoimmune Diseases | Aberrant MHC presentation can trigger autoimmune responses (e.g., Type 1 diabetes, rheumatoid arthritis). |
| Transplant Rejection | MHC molecules are critical for tissue compatibility; mismatches trigger rejection. |
| Cancer | Downregulation of MHC class I by tumor cells allows them to evade immune surveillance. |
| Vaccines | Effective vaccines require antigens that can be presented by MHC class I or II molecules to elicit strong immune responses. |
7. Summary Table
| Feature | MHC Class I | MHC Class II |
|---|---|---|
| Expression | All nucleated cells. | Antigen-presenting cells (APCs). |
| T Cell Interaction | CD8+ cytotoxic T cells. | CD4+ helper T cells. |
| Antigen Source | Endogenous (intracellular pathogens). | Exogenous (extracellular pathogens). |
| Peptide Length | 8–10 amino acids. | 13–25 amino acids. |
| Function | Cytotoxic T cell activation; cell killing. | Helper T cell activation; immune coordination. |
Conclusion
MHC class I and class II molecules are indispensable components of the adaptive immune system, enabling the recognition and elimination of pathogens and abnormal cells. While MHC class I activates cytotoxic responses to intracellular threats, MHC class II orchestrates helper T cell-mediated responses to extracellular pathogens. Understanding these molecules is key to advancing immunotherapy, vaccine development, and transplant medicine.
Detect MHC & HLA in your lab
Assay Genie supplies validated MHC and HLA antibodies for flow cytometry, in vivo studies and functional immunology — purified and fluorophore-conjugated formats for human and mouse research.
Anti-Human HLA-DR [L243]
Purified MHC class II (HLA-DR) antibody for FCM, WB, IHC and IP in human samples.
View antibody
Anti-Mouse MHC II (I-A/I-E) [M5/114] AF647
GenieFluor 647-conjugated MHC class II antibody for flow cytometry in mouse samples.
View antibody
Anti-Mouse H-2Kb (MHC Class I) [Y-3]
Low-endotoxin in vivo MHC class I antibody for functional mouse studies.
View antibodyStudying antigen presentation?
From MHC and HLA detection to full immunophenotyping panels, Assay Genie's validated flow cytometry antibodies give you publication-ready data — backed by expert technical support from our PhD team.
Explore Flow Cytometry Antibodies →Frequently asked questions
What is the main difference between MHC class I and class II?
MHC class I is expressed on all nucleated cells and presents endogenous (intracellular) antigens to CD8+ cytotoxic T cells. MHC class II is restricted to antigen-presenting cells and presents exogenous (extracellular) antigens to CD4+ helper T cells.
Which cells express MHC class II?
MHC class II is restricted to professional antigen-presenting cells (APCs), including dendritic cells, macrophages and B cells.
What length of peptides do MHC molecules bind?
MHC class I has a closed-ended groove that binds short peptides of 8–10 amino acids, while MHC class II has an open-ended groove that binds longer peptides of 13–25 amino acids.
How do tumors use MHC to evade the immune system?
Some tumor cells downregulate MHC class I, reducing the display of tumor antigens on their surface. This lets them evade recognition and killing by CD8+ cytotoxic T cells (immune surveillance).
Why does MHC matter for transplantation?
MHC (HLA in humans) molecules determine tissue compatibility. Mismatches between donor and recipient MHC trigger transplant rejection, so MHC typing is central to matching for transplants.
References
- Alberts, B., et al., 2015. Molecular Biology of the Cell. 6th Edition. Garland Science.
- Janeway, C.A., et al., 2001. Immunobiology: The Immune System in Health and Disease. Garland Publishing.
- Neefjes, J., et al., 2011. MHC class I and II antigen presentation. Nature Reviews Immunology, 11(12), pp.823-836.
- Rock, K.L., et al., 2016. Pathways of antigen processing and presentation. Immunology Reviews, 272(1), pp.9-27.
- Klein, J., Sato, A., 2000. The HLA system: Genetics, immunology, clinical testing, and clinical implications. Blood, 95(8), pp.2607-2620.
Related articles
Recent Posts
-
ELISA vs Western Blot: Which Technique Should You Choose?
Written by Seán Mac Fhearraigh, PhD  • Updated: 19 May 2026  • ~9 min read Quick Answer ELISA …20th May 2026 -
Types of ELISA: Direct, Indirect, Sandwich & Competitive Compared
Written by Seán Mac Fhearraigh, PhD  • Updated: 19 May 2026  • ~9 min read Quick Answer The fi …20th May 2026 -
Sandwich ELISA: Step-by-Step Protocol & Troubleshooting
Written by Seán Mac Fhearraigh, PhD  • Updated: 19 May 2026  • ~ …20th May 2026